Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Harnessing the effects of hypoxia-like inhibition on homology-directed DNA repair

Seminars in Cancer Biology(2023)10.1016/j.semcancer.2023.11.007Source: DataRank Database

Harnessing the effects of hypoxia-like inhibition on homology-directed DNA repair is a research paper published in Seminars in Cancer Biology (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.27)OA: greenTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Maddie Ghazarian,Peter M. Glazer ORCID,Gary Altwerger ORCID

Live enrichment

PubMed:38029867 PMC:PMC10872265 OpenAlex:https://openalex.org/W4389068221

National Institutes of Health

Grant: R01ES005775

National Institutes of Health

Grant: R35CA197574

National Institute of Child Health and Human Development

Grant: K12-HD047018

NCATS NIH HHS

Grant: UL1 TR001863

NICHD NIH HHS

Grant: K12 HD047018

FWCI

1.27

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10872265/pdf/nihms-1951887.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1044579X23001487?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1044579X23001487?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10872265

Fields of Study

PARP inhibition in cancer therapyDNA Repair MechanismsAutophagy in Disease and TherapyHumansPoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesDNA RepairAntineoplastic AgentsNeoplasmsHypoxiaTumor Microenvironment

MeSH Terms

Poly(ADP-ribose) Polymerase InhibitorsHypoxiaAntineoplastic AgentsDNA RepairHumansNeoplasmsPoly(ADP-ribose) PolymerasesTumor Microenvironment

Keywords

Synthetic lethalityPoly ADP ribose polymeraseDNA repairDownregulation and upregulationCancer researchPARP inhibitorImmunotherapyPopulationDNA damageHypoxia (environmental)PharmacologyBiologyMedicinePolymeraseDNAImmunologyChemistryImmune systemGeneticsGeneHypoxiaimmune therapyHomologous RecombinationBrcaRad51CediranibImmune Checkpoint Inhibitors

Sustainable Development Goals

SDG 0: Good health and well-being

Harnessing the effects of hypoxia-like inhibition on homology-directed DNA repair

FAIR Checklist

Authors (3)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)